Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7600-0.0278 (-3.53%)
At close: 4:00PM EDT
0.8750 +0.12 (+15.13%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.7878
Open0.7900
Bid0.8740 x 1300
Ask0.8750 x 1400
Day's Range0.7387 - 0.7900
52 Week Range0.6560 - 3.7700
Volume2,637,595
Avg. Volume1,129,776
Market Cap90.947M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)-0.7730
Earnings DateNov. 10, 2021 - Nov. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.83
  • GlobeNewswire

    Agile Therapeutics Applauds Congressional Chairs’ Letter to Biden Administration Requesting Enforcement of Contraceptive Access Under Affordable Care Act

    PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries of U.S. Departments of Health and Human Services (HHS), Treasury, and Labor to enforce the law regarding women’s access to contraceptive methods as dictated by the Affordable Care Act (ACA). "We applaud the authors of the letter, Energy and Commerce Chairman, Frank Pallone Jr., Ways and Means Comm

  • GlobeNewswire

    Agile Therapeutics Appoints Josephine Torrente to its Board of Directors

    PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Josephine Torrente has been appointed to the Company’s board of directors, as a Class II director, effective as of October 7, 2021. Ms. Torrente will serve on Agile’s Science and Technology Committee and Nominating and Corporate Governance Committee. “Josephine is a keen regulatory strategist with extensive experience guiding new drug therapies through th

  • GlobeNewswire

    Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

    PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants to purchase 13,333,324 shares of its common stock at a combined offering price to the public of $0.85 per one share of common stock and one-half of a warrant to purchase one share of common stock. The warrants have an exercise price of $0.85 per share of commo